ESTRO 2024 - Abstract Book

S2631

Clinical - Urology

ESTRO 2024

Fig. 5 Cumulative incidence of GI toxicity ≥ G2

Conclusion:

Based on the current analysis, that indicates a high recurrence rate, it is crucial to continue offering potentially curative salvage treatment. In the era of PSMA-PET and WB-MRI, with the capability to detect distant metastatic disease early, it's essential to choose patients for these examinations using specific criteria and clinical stratification. Both current and future analyses will establish a foundation for a better understanding of how to tailor care for these patients.

Keywords: Salvage radiotherapy, Prostate, multicentric

3182

Digital Poster

The evolution of Imaging Modalities in omHSPCa: a shifting paradigm

Federico Mastroleo 1,2 , Riccardo Villa 1,3 , Ekaterina Milovanova 1,3 , Lorenzo Colombi 1,3 , Constantinos Zamboglou 4,5 , Francesco Ceci 6,3 , Giuseppe Petralia 7,3 , Maria Giulia Vincini 1 , Mattia Zaffaroni 1 , Giulia Marvaso 1,3 , Pierfrancesco Franco 8 , Barbara Alicja Jereczek-Fossa 1,3 1 IEO European Institute of Oncology IRCCS, Division of Radiation Oncology, Milan, Italy. 2 University of Piemonte Orientale, Department of Translational Medicine, Milan, Italy. 3 University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy. 4 University Hospital Freiburg, Department of Radiotherapy, Freiburg, Germany. 5 German Oncology Center, Division of Radiation Oncology, Limassol, Cyprus. 6 IEO European Institute of Oncology IRCCS, Division of Nuclear Medicine, Milan, Italy. 7 IEO European Institute of Oncology IRCCS, Division of Radiology, Milan, Italy. 8 University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy